Targeting CD38 with Daratumumab Plus Chemotherapy for Patients with Advanced-Stage Plasmablastoid Large B-Cell Lymphoma

Plasmablastic lymphoma (PBL) is a rare and aggressive form of large B-cell lymphoma (LBCL) most commonly seen in the setting of chronic immunosuppression or autoimmune disease. The prognosis is poor and CHOP-like regimens often fail to produce durable remission; therefore, there is no established st...

Descripción completa

Detalles Bibliográficos
Autores principales: Ryu, Yun Kyoung, Ricker, Edd C., Soderquist, Craig R., Francescone, Mark A., Lipsky, Andrew H., Amengual, Jennifer E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9409851/
https://www.ncbi.nlm.nih.gov/pubmed/36013165
http://dx.doi.org/10.3390/jcm11164928

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9409851/
https://www.ncbi.nlm.nih.gov/pubmed/36013165
http://dx.doi.org/10.3390/jcm11164928

Ejemplares similares